Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy The Joint stock

Learn how to easily invest in The Joint stock.

The Joint Corp is a medical care facilities business based in the US. The Joint shares (JYNT) are listed on the NASDAQ and all prices are listed in US Dollars. The Joint employs 316 staff and has a trailing 12-month revenue of around $90.6 million.

How to buy shares in The Joint

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – JYNT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

The Joint stock price (NASDAQ: JYNT)

Use our graph to track the performance of JYNT stocks over time.

The Joint shares at a glance

Information last updated 2022-10-03.
Latest market close$15.92
52-week range$13.10 - $103.30
50-day moving average $18.39
200-day moving average $30.79
Wall St. target price$31.50
PE ratio 148.2727
Dividend yield $0 (0%)
Earnings per share (TTM) $0.11

Buy The Joint shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy The Joint stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

The Joint price performance over time

Historical closes compared with the close of $15.92 from 2022-10-03

1 week (2022-09-28) -0.50%
1 month (2022-09-02) -5.69%
3 months (2022-07-05) -4.10%
6 months (2022-04-05) -54.28%
1 year (2021-10-05) -83.26%
2 years (2020-10-05) -11.56%
3 years (2019-10-04) 17.99
5 years (2017-10-04) 224.24%

Is The Joint stock undervalued or overvalued?

Valuing The Joint stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Joint's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

The Joint's P/E ratio

The Joint's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 148x. In other words, The Joint shares trade at around 148x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

The Joint's EBITDA

The Joint's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $8.6 million.

The EBITDA is a measure of a The Joint's overall financial performance and is widely used to measure a its profitability.

The Joint financials

Revenue TTM $90.6 million
Operating margin TTM 1.93%
Gross profit TTM $72.3 million
Return on assets TTM 1.33%
Return on equity TTM 5.98%
Profit margin 1.89%
Book value $2.10
Market capitalisation $236.4 million

TTM: trailing 12 months

The Joint share dividends

We're not expecting The Joint to pay a dividend over the next 12 months.

The Joint share price volatility

Over the last 12 months, The Joint's shares have ranged in value from as little as $13.1 up to $103.3. A popular way to gauge a stock's volatility is its "beta".

JYNT.US volatility(beta: 1.3)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while The Joint's is 1.2964. This would suggest that The Joint's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

The Joint overview

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Frequently asked questions

What percentage of The Joint is owned by insiders or institutions?
Currently 3.515% of The Joint shares are held by insiders and 91.767% by institutions.
How many people work for The Joint?
Latest data suggests 316 work at The Joint.
When does the fiscal year end for The Joint?
The Joint's fiscal year ends in December.
Where is The Joint based?
The Joint's address is: 16767 North Perimeter Drive, Scottsdale, AZ, United States, 85260
What is The Joint's ISIN number?
The Joint's international securities identification number is: US47973J1025
What is The Joint's CUSIP number?
The Joint's Committee on Uniform Securities Identification Procedures number is: 47973J102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site